SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $60,000 | -27.7% | 532,671 | +987.0% | 0.00% | – |
| Q3 2018 | $83,000 | -80.4% | 49,006 | -79.9% | 0.00% | – |
| Q2 2018 | $423,000 | -65.0% | 243,363 | -63.1% | 0.00% | – |
| Q1 2018 | $1,207,000 | +881.3% | 659,278 | +1103.1% | 0.00% | – |
| Q4 2017 | $123,000 | -52.0% | 54,800 | -37.9% | 0.00% | – |
| Q3 2017 | $256,000 | +16.4% | 88,245 | +78.2% | 0.00% | – |
| Q2 2017 | $220,000 | -55.0% | 49,533 | -52.8% | 0.00% | – |
| Q1 2017 | $489,000 | +35.5% | 104,853 | +76.8% | 0.00% | – |
| Q4 2016 | $361,000 | +149.0% | 59,299 | +125.8% | 0.00% | – |
| Q3 2016 | $145,000 | -1.4% | 26,262 | -32.0% | 0.00% | – |
| Q2 2016 | $147,000 | +137.1% | 38,643 | +73.2% | 0.00% | – |
| Q1 2016 | $62,000 | -75.0% | 22,314 | -49.1% | 0.00% | – |
| Q4 2015 | $248,000 | +66.4% | 43,847 | +56.5% | 0.00% | – |
| Q3 2015 | $149,000 | -40.6% | 28,026 | -7.4% | 0.00% | – |
| Q2 2015 | $251,000 | +258.6% | 30,280 | +98.2% | 0.00% | – |
| Q1 2015 | $70,000 | -24.7% | 15,275 | -49.9% | 0.00% | – |
| Q4 2014 | $93,000 | -50.3% | 30,519 | -54.4% | 0.00% | – |
| Q3 2014 | $187,000 | -61.4% | 66,891 | -44.0% | 0.00% | – |
| Q2 2014 | $485,000 | +73.8% | 119,369 | +127.4% | 0.00% | – |
| Q1 2014 | $279,000 | +10.3% | 52,500 | +17.0% | 0.00% | – |
| Q4 2013 | $253,000 | +224.4% | 44,882 | +164.2% | 0.00% | – |
| Q3 2013 | $78,000 | -70.7% | 16,991 | -72.4% | 0.00% | – |
| Q2 2013 | $266,000 | – | 61,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|